Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Regional Cooling System Improves Outcomes of Cardiac Arrest Victims

By HospiMedica International staff writers
Posted on 03 Aug 2011
A new study has found that coordinated therapeutic hypothermia (TH) increases the portion of survivors with good brain function by cooling, then gradually rewarming people who had been resuscitated after an out-of-hospital cardiac arrest (OHCA).

Researchers at the Minneapolis Heart Institute Foundation (MN, USA) developed the Cool It protocol, which established TH as the standard of care for OHCA across a regional network of hospitals transferring patients to a central TH-capable hospital. More...
Between February 2006 and August 2009, 140 OHCA patients who remained unresponsive after return of spontaneous circulation were cooled and then rewarmed with the use of an automated, noninvasive cooling device; 75% of them were transferred to the central TH hospital. Positive neurological outcome was defined as Cerebral Performance Category (CPC) of 1 or 2 at discharge.

An analysis of the results showed that overall survival to hospital discharge was 56%, and 92% of survivors were discharged with a positive neurological outcome; survival was similar in transferred and nontransferred patients. Nonventricular fibrillation arrest and presence of cardiogenic shock were associated strongly with mortality, but survivors with these event characteristics had high rates of positive neurological recovery (100% and 89%, respectively). A 20% increase in the risk of death was observed for every hour of delay to initiation of cooling. The study was published in the July 12, 2011, issue of Circulation.

"We've shown that a fully integrated system of care, from EMS through hospital discharge, can provide this essential therapy to victims of out-of-hospital cardiac arrest across a broad geographic region,” said lead author Michael Mooney, MD, director of the TH program at the Minneapolis Heart Institute. “If you have a cardiac arrest 200 miles away or on our doorstep, the quality of the outcomes is identical.”

Therapeutic hypothermia, also known as protective hypothermia, is a medical treatment that lowers a patient's body temperature to help reduce the risk of the ischemic injury to tissue following a period of insufficient blood flow. This may be due to cardiac arrest or the occlusion of an artery by an embolism, as occurs in the case of strokes. TH may be induced by invasive means, in which a catheter is placed in the inferior vena cava via the femoral vein, or by noninvasive means, usually involving ice packs, a chilled water blanket or torso vest, and leg wraps in direct contact with the patient's skin.

Related Links:
Minneapolis Heart Institute Foundation



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.